BRPI0410951A - nucleotìdeos para prevenção e tratamento de patologias bacterianas e fungicas - Google Patents
nucleotìdeos para prevenção e tratamento de patologias bacterianas e fungicasInfo
- Publication number
- BRPI0410951A BRPI0410951A BRPI0410951-1A BRPI0410951A BRPI0410951A BR PI0410951 A BRPI0410951 A BR PI0410951A BR PI0410951 A BRPI0410951 A BR PI0410951A BR PI0410951 A BRPI0410951 A BR PI0410951A
- Authority
- BR
- Brazil
- Prior art keywords
- ssdna
- bacterial
- library
- odns
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/127—DNAzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/11—Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/30—Production chemically synthesised
- C12N2330/31—Libraries, arrays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"NUCLEOTìDEOS PARA A PREVENçãO E O TRATAMENTO DE PATOLOGIAS BACTERIANAS E FUNGICAS". Uma biblioteca da expressão de DNA de fita simples (ssDNA) seletivamente induzível, um método para construir uma biblioteca da expressão de ssDNA, um método para selecionar o ssDNA usando a biblioteca da expressão, e um método para identificar as moléculas do ssDNA que alteram a expressão do gene (s) bacterianos e fúngicos relacionados ao crescimento da célula e à produção e à secreção de toxina. A biblioteca da seleção é usada para, entre outras coisas, identificar os ODNs eficazes em parar o crescimento da célula, em matar bactérias ou fungos, ou em impedir que as bactérias e/ou os fungos sintetizem e secretem suas toxinas, e/ou para descobrir os ODNs eficazes em células de eucarióticos (por exemplo, mamíferos) para a alteração alvo da função do gene. A biblioteca é também útil para identificar os ssDNAs ou o ODNs que são usados como agentes terapêuticos, por exemplo, fornecendo um método para o tratamento de infecções bacterianas, tais como, a sepsis.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/453,410 US20040248101A1 (en) | 2003-06-03 | 2003-06-03 | Identification of novel antibacteria agents by screening the single-stranded DNA expression library |
US10/743,956 US20050136393A1 (en) | 2003-12-23 | 2003-12-23 | Oligodoxynucleotide (ODN) libraries, their use in screening for antibacterial agents, and catalytic ODN sequence for use as an antibacterial agent |
US10/818,158 US20050020526A1 (en) | 2003-06-03 | 2004-04-05 | Oligodeoxynucleotide intervention for prevention and treatment of sepsis |
PCT/US2004/017331 WO2004108840A2 (en) | 2003-06-03 | 2004-06-03 | Nucleotides for prevention and treatment of bacterial and fungal pathologies |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0410951A true BRPI0410951A (pt) | 2006-07-25 |
Family
ID=33514683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0410951-1A BRPI0410951A (pt) | 2003-06-03 | 2004-06-03 | nucleotìdeos para prevenção e tratamento de patologias bacterianas e fungicas |
Country Status (9)
Country | Link |
---|---|
US (3) | US20050020526A1 (pt) |
EP (1) | EP1646719A2 (pt) |
JP (1) | JP2006526416A (pt) |
KR (1) | KR20060065580A (pt) |
AU (1) | AU2004245978A1 (pt) |
BR (1) | BRPI0410951A (pt) |
CA (1) | CA2528131A1 (pt) |
IL (1) | IL172324A0 (pt) |
WO (1) | WO2004108840A2 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070160581A1 (en) * | 1994-04-29 | 2007-07-12 | Cytogenix, Inc. | Production of ssDNA in vivo |
US6951652B2 (en) * | 1998-07-29 | 2005-10-04 | Biosynth S.R.L. | Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases |
US20050260588A1 (en) * | 2002-05-01 | 2005-11-24 | Conrad Charles A | In vivo ssdna expression vectors for altering gene expression |
US20050020526A1 (en) * | 2003-06-03 | 2005-01-27 | Cytogenix, Inc. | Oligodeoxynucleotide intervention for prevention and treatment of sepsis |
WO2006037127A2 (en) * | 2004-09-28 | 2006-04-06 | Cytogenix, Inc. | Single-stranded antimicrobial oligonucleotides and uses thereof |
CN103361321B (zh) * | 2013-06-27 | 2015-02-18 | 华东理工大学 | 一种ssDNA-蛋白质酶法交联方法 |
JP6459962B2 (ja) * | 2013-10-21 | 2019-01-30 | 味の素株式会社 | L−アミノ酸の製造法 |
CN110242244B (zh) * | 2014-03-07 | 2021-09-07 | 株式会社吴羽 | 钻井用堵塞器 |
AU2014400642B2 (en) * | 2014-07-07 | 2018-01-04 | Halliburton Energy Services, Inc. | Downhole tools comprising aqueous-degradable sealing elements |
KR101675359B1 (ko) * | 2014-12-30 | 2016-11-14 | 건국대학교 글로컬산학협력단 | 네오아가로올리고당을 유효성분으로 포함하는 패혈증 또는 패혈증성 쇼크의 예방 또는 치료용 조성물 |
US20180002692A1 (en) * | 2015-01-30 | 2018-01-04 | Anushree Chatterjee | Sequence Specific and Organism Specific Antimicrobials and Related Materials and Methods |
US10472918B2 (en) * | 2015-10-28 | 2019-11-12 | Halliburton Energy Services, Inc. | Degradable isolation devices with embedded tracers |
EP3263115A1 (de) * | 2016-06-30 | 2018-01-03 | Technische Hochschule Mittelhessen | Erfindung betreffend wirkstoff gegen pseudomonas aeruginosa |
CN108315452B (zh) * | 2018-04-28 | 2021-02-12 | 内蒙古农业大学 | 一种用于肠道中双歧杆菌属定量的引物及定量方法 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5190931A (en) * | 1983-10-20 | 1993-03-02 | The Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
US5208149A (en) * | 1983-10-20 | 1993-05-04 | The Research Foundation Of State University Of New York | Nucleic acid constructs containing stable stem and loop structures |
US5272065A (en) * | 1983-10-20 | 1993-12-21 | Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
US5294533A (en) * | 1988-07-05 | 1994-03-15 | Baylor College Of Medicine | Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
US5098890A (en) * | 1988-11-07 | 1992-03-24 | Temple University-Of The Commonwealth System Of Higher Education | Antisence oligonucleotides to c-myb proto-oncogene and uses thereof |
US5436141A (en) * | 1989-02-24 | 1995-07-25 | University Of Medicine And Dentistry Of New Jersey | Method for synthesizing stable single-stranded CDNA in eukaryotes by means of a bacterial retron and products |
US5514577A (en) * | 1990-02-26 | 1996-05-07 | Isis Pharmaceuticals, Inc. | Oligonucleotide therapies for modulating the effects of herpes viruses |
US5503978A (en) * | 1990-06-11 | 1996-04-02 | University Research Corporation | Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
US5843738A (en) * | 1990-08-14 | 1998-12-01 | Isis Pharmaceuticals, Inc. | Oligonucleotide modulation of cell adhesion |
US5442049A (en) * | 1992-11-19 | 1995-08-15 | Isis Pharmaceuticals, Inc. | Oligonucleotides for modulating the effects of cytomegalovirus infections |
US5840867A (en) * | 1991-02-21 | 1998-11-24 | Gilead Sciences, Inc. | Aptamer analogs specific for biomolecules |
US5714323A (en) * | 1991-08-30 | 1998-02-03 | The University Of Medecine And Dentistry Of New Jersey | Over expression of single-stranded molecules |
US5756291A (en) * | 1992-08-21 | 1998-05-26 | Gilead Sciences, Inc. | Aptamers specific for biomolecules and methods of making |
US5962426A (en) * | 1993-06-25 | 1999-10-05 | Yale University | Triple-helix forming oligonucleotides for targeted mutagenesis |
US5739309A (en) * | 1993-07-19 | 1998-04-14 | Gen-Probe Incorporated | Enhancement of oligonucleotide inhibition of protein production, cell proliferation and / or multiplication of infectious disease pathogens |
US6054299A (en) * | 1994-04-29 | 2000-04-25 | Conrad; Charles A. | Stem-loop cloning vector and method |
US5807718A (en) * | 1994-12-02 | 1998-09-15 | The Scripps Research Institute | Enzymatic DNA molecules |
US7034009B2 (en) * | 1995-10-26 | 2006-04-25 | Sirna Therapeutics, Inc. | Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R) |
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
US6057367A (en) * | 1996-08-30 | 2000-05-02 | Duke University | Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses |
US5919677A (en) * | 1997-05-09 | 1999-07-06 | The Research Foundation Of State University Of New York | Eukaryotic and retroviral antisense initiator elements |
US6300318B1 (en) * | 1997-09-16 | 2001-10-09 | Peter E. Nielsen | Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor |
JP2003525017A (ja) * | 1998-04-20 | 2003-08-26 | リボザイム・ファーマシューティカルズ・インコーポレーテッド | 遺伝子発現を調節しうる新規な化学組成を有する核酸分子 |
AU6298899A (en) * | 1998-10-09 | 2000-05-01 | Ingene, Inc. | Production of ssdna (in vivo) |
AUPP810399A0 (en) * | 1999-01-11 | 1999-02-04 | Unisearch Limited | Catalytic molecules |
AU4028800A (en) * | 1999-04-02 | 2000-10-23 | City Of Hope | Method for identifying accessible binding sites on rna |
US7419964B2 (en) * | 1999-09-16 | 2008-09-02 | Cytogenix, Inc. | Treatment of HSV-related pathologies using ssDNA |
MXPA02003422A (es) * | 1999-10-04 | 2004-09-10 | Cytogenix Inc | Alteracion de la expresion de genes con adnss producido in vivo. |
US20070026394A1 (en) * | 2000-02-11 | 2007-02-01 | Lawrence Blatt | Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies |
EP1468086A2 (en) * | 2001-12-14 | 2004-10-20 | Yale University | INTRACELLULAR GENERATION OF SINGLE−STRANDED DNA |
US20050020526A1 (en) * | 2003-06-03 | 2005-01-27 | Cytogenix, Inc. | Oligodeoxynucleotide intervention for prevention and treatment of sepsis |
US20040248101A1 (en) * | 2003-06-03 | 2004-12-09 | Cytogenix, Inc. | Identification of novel antibacteria agents by screening the single-stranded DNA expression library |
US20050136393A1 (en) * | 2003-12-23 | 2005-06-23 | Cytogenix, Inc. | Oligodoxynucleotide (ODN) libraries, their use in screening for antibacterial agents, and catalytic ODN sequence for use as an antibacterial agent |
WO2006037127A2 (en) * | 2004-09-28 | 2006-04-06 | Cytogenix, Inc. | Single-stranded antimicrobial oligonucleotides and uses thereof |
-
2004
- 2004-04-05 US US10/818,158 patent/US20050020526A1/en not_active Abandoned
- 2004-06-03 JP JP2006515087A patent/JP2006526416A/ja not_active Withdrawn
- 2004-06-03 US US10/574,254 patent/US8889397B2/en not_active Expired - Fee Related
- 2004-06-03 WO PCT/US2004/017331 patent/WO2004108840A2/en active Application Filing
- 2004-06-03 CA CA002528131A patent/CA2528131A1/en not_active Abandoned
- 2004-06-03 EP EP04754036A patent/EP1646719A2/en not_active Withdrawn
- 2004-06-03 AU AU2004245978A patent/AU2004245978A1/en not_active Abandoned
- 2004-06-03 KR KR1020057023173A patent/KR20060065580A/ko not_active Application Discontinuation
- 2004-06-03 BR BRPI0410951-1A patent/BRPI0410951A/pt not_active IP Right Cessation
-
2005
- 2005-12-01 IL IL172324A patent/IL172324A0/en unknown
-
2014
- 2014-10-27 US US14/524,744 patent/US20150094236A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004108840A8 (en) | 2005-06-16 |
WO2004108840A2 (en) | 2004-12-16 |
US20070020635A1 (en) | 2007-01-25 |
CA2528131A1 (en) | 2004-12-16 |
US8889397B2 (en) | 2014-11-18 |
US20150094236A1 (en) | 2015-04-02 |
JP2006526416A (ja) | 2006-11-24 |
AU2004245978A1 (en) | 2004-12-16 |
KR20060065580A (ko) | 2006-06-14 |
IL172324A0 (en) | 2009-02-11 |
US20050020526A1 (en) | 2005-01-27 |
EP1646719A2 (en) | 2006-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity | |
Xu et al. | Discovery of a cryptic antifungal compound from Streptomyces albus J1074 using high-throughput elicitor screens | |
Vogel et al. | The digestive and defensive basis of carcass utilization by the burying beetle and its microbiota | |
Miwa et al. | How effectors promote beneficial interactions | |
Dong et al. | Generation of reactive oxygen species by lethal attacks from competing microbes | |
Jones et al. | ChIP-Seq and RNA-Seq reveal an AmrZ-mediated mechanism for cyclic di-GMP synthesis and biofilm development by Pseudomonas aeruginosa | |
Li et al. | LPS remodeling is an evolved survival strategy for bacteria | |
Allocati et al. | Die for the community: an overview of programmed cell death in bacteria | |
Lee et al. | Discovery of a widely distributed toxin biosynthetic gene cluster | |
BRPI0410951A (pt) | nucleotìdeos para prevenção e tratamento de patologias bacterianas e fungicas | |
O’Brien et al. | An ecological perspective of microbial secondary metabolism | |
Stubbendieck et al. | Escape from lethal bacterial competition through coupled activation of antibiotic resistance and a mobilized subpopulation | |
Sprague et al. | Eukaryotes learn how to count: quorum sensing by yeast | |
Couzigou et al. | miRNA-encoded peptides (miPEPs): a new tool to analyze the roles of miRNAs in plant biology | |
Briones-Roblero et al. | Structure and dynamics of the gut bacterial microbiota of the bark beetle, Dendroctonus rhizophagus (Curculionidae: Scolytinae) across their life stages | |
Beljantseva et al. | Negative allosteric regulation of Enterococcus faecalis small alarmone synthetase RelQ by single-stranded RNA | |
Kim et al. | An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs | |
BR0308424A (pt) | Métodos e meios para infra-regular eficientemente a expressão de qualquer gene de interesse em células e organismos eucarióticos | |
Popp et al. | Coordinated cell death in isogenic bacterial populations: sacrificing some for the benefit of many? | |
Riquelme et al. | Biotechnological potential of Actinobacteria from Canadian and Azorean volcanic caves | |
Duceppe et al. | Analysis of survival and hatching transcriptomes from potato cyst nematodes, Globodera rostochiensis and G. pallida | |
Baumann et al. | Selection and evaluation of tissue specific reference genes in Lucilia sericata during an immune challenge | |
Costerton | Microbial ecology comes of age and joins the general ecology community | |
Xiao et al. | An IMD-like pathway mediates the intestinal immunity to modulate the homeostasis of gut microbiota in Rhynchophorus ferrugineus Olivier (Coleoptera: Dryophthoridae) | |
Sulaiman et al. | Application of proteomics in studying bacterial persistence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |